摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Cbz-Pro-ψ[CH2SO2]-Cl | 212204-36-9

中文名称
——
中文别名
——
英文名称
Cbz-Pro-ψ[CH2SO2]-Cl
英文别名
Cbz-(S)-HPrs-Cl;Cbz-(S)-2-pyrrolidinemethanesulfonyl chloride;(S)-2-Chlorosulfonylmethyl-pyrrolidine-1-carboxylic acid benzyl ester;benzyl (2S)-2-(chlorosulfonylmethyl)pyrrolidine-1-carboxylate
Cbz-Pro-ψ[CH2SO2]-Cl化学式
CAS
212204-36-9
化学式
C13H16ClNO4S
mdl
——
分子量
317.793
InChiKey
WFSXSKWRWQOOAY-LBPRGKRZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    20
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    72.1
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2933990090

SDS

SDS:62023e8ac3dee92c22d199e3763ad986
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    包含2-吡咯烷甲磺酸(2PyMS)残基的肽的构象行为†
    摘要:
    使用X射线,NMR和IR实验研究了含有2-吡咯烷甲磺酸(2PyMS)残基的模型肽的结晶状态和溶液中的构象行为。结果发现,在晶体中,二肽PhC(O)-2PyMS-Phe-NHiPr具有β-转构型,分子内氢键无法稳定该构型,可以归为IV型β-转型。在晶体状态下,三肽PhC(O)–翼–2PyMS–Phe–NHiPr以α-转角的形式存在,由2PyMS残基的吡咯烷氮原子形成的酰胺键具有不常见的顺式构象,到目前为止,在确定的紧密转弯中尚无紧密的类似物。尽管采用折叠构象的趋势仅部分保留在溶液中,但是2-PyMS可以被认为是设计具有非常规构象性质的折叠剂和拟肽的有前途的结构单元。
    DOI:
    10.1039/c2ob27058g
  • 作为产物:
    参考文献:
    名称:
    高效而简便的合成 ñ-Cbz-β-氨基链烷磺酰胺
    摘要:
    描述了一种合成N -Cbz-β-氨基链烷磺酰胺的有效方法。N -Cbz-β-氨基链烷磺酰胺很容易以高收率由多种氨基醇(包括旋光性氨基醇)制备,方法是用氯甲酸苄酯进行N -Cbz保护,用硫代乙酸进行Mitsunobu酯化反应,N-氯代琥珀酰亚胺氧化和氨解处理。
    DOI:
    10.1007/s11426-012-4607-9
点击查看最新优质反应信息

文献信息

  • Efficient synthesis of protected sulfonopeptides from N-protected 2-aminoalkyl xanthates and thioacetates
    作者:Saeed Kakaei、Jiaxi Xu
    DOI:10.1016/j.tet.2013.08.028
    日期:2013.10
    An efficient and convenient method was developed for the synthesis of protected sulfonopeptides via N-chlorosuccimide (NCS)/HCI oxidative chlorination of N-protected 2-aminoallcyl xanthates or thioacetates to the corresponding sulfonyl chlorides followed by aminolysis with amino esters. In the current method, sulfonopeptides containing 1- and 2-substituted taurines were prepared in satisfactory to good yields. It is a useful and efficient strategy for the synthesis of protected sulfonopeptides with functionalized side-chains. (C) 2013 Elsevier Ltd. All rights reserved.
  • Investigation of a New Family of Chiral Ligands for Enantioselective Catalysis via Parallel Synthesis and High-Throughput Screening
    作者:Cesare Gennari、Simona Ceccarelli、Umberto Piarulli、Christian A. G. N. Montalbetti、Richard F. W. Jackson
    DOI:10.1021/jo980890p
    日期:1998.8.1
  • Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2
    作者:Cesare Giordano、Anna Sansone、Annalisa Masi、Gino Lucente、Pasqualina Punzi、Adriano Mollica、Francesco Pinnen、Federica Feliciani、Ivana Cacciatore、Peg Davis
    DOI:10.1016/j.ejmech.2010.07.022
    日期:2010.10
    The opioid agonists endomorphins (Tyr-Pro-Trp-Phe-NH(2); EM1 and Tyr-Pro-Phe-Phe-NH(2); EM2) and morphiceptin (Tyr-Pro-Phe-Pro-NH(2)) exhibit an extremely high selectivity for mu-opioid receptor. Here a series of novel EM2 and morphiceptin analogues containing in place of the proline at position 2 the S and R residues of beta-homologues of proline (HPro), of 2-pyrrolidinemethanesulphonic acid (HPrs) and of 3-pyrrolidinesulphonic acid (beta Prs) have been synthesized and their binding affinity and functional activity have been investigated. The highest p-receptor affinity is shown by [(S)beta Prs(2)]EM2 analogue (6e) which represents the first example of a beta-sulphonamido analogue in the field of mold peptides. (C) 2010 Elsevier Masson SAS. All rights reserved.
  • Synthesis and activity of fibrillogenesis peptide inhibitors related to the 17–21 β-amyloid sequence
    作者:Cesare Giordano、Annalisa Masi、Aldo Pizzini、Anna Sansone、Valerio Consalvi、Roberta Chiaraluce、Gino Lucente
    DOI:10.1016/j.ejmech.2008.03.036
    日期:2009.1
    Peptide derivatives 1-5, incorporating synthetic non-proteinogenic amino acids, related to the beta-amyloid 17-21 fragment of the amyloidogenic A beta(1-40), and the N-protected decapeptide 6, corresponding to a dimeric sequence of the same fragment, have been synthesized. These compounds were designed by using Soto's pentapeptide Ac-LPFFD-NH2 (iA beta 5p) as lead compound. Their activity as inhibitors of fibrillogenesis and stability against enzymatic degradation have been determined. Compounds 1, 5 and 6 are potent inhibitors in comparison to the lead compound. Exposure to chymotrypsin of peptide derivatives 1-5, all containing unnatural amino acids, shows increased stability as compared with iA beta 5p and 6. Conformational properties of the new compounds have been determined by CD and FF-IR spectroscopies. (C) 2008 Elsevier Masson SAS. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫